News & Articles

HCF Catalyst Accelerator Program - A Recount by Lauren Devine

July 10, 2020

The Good Science Co (musculoskeletal health research team from the University of Newcastle and Hunter New England Population Health) recently participated in the HCF Catalyst Accelerator program for health-tech startups. Here is a brief recount on their experience by Lauren Devine.

Hunter Researchers Awarded Competitive Cardiovascular Grants

May 1, 2020

Over $20 million in funding has been awarded to NSW cardiovascular researchers, with HMRI affiliated researchers to share in the funds.

Coping with trauma and anxiety during COVID-19

April 29, 2020

The bushfires, floods and now the COVID-19 pandemic have had an ongoing impact on many people’s anxiety levels for months. For many Australians, this has had a cumulative impact on their mental health and wellbeing. In situations like this, our minds are responding to a perceived threat has been continuing for months.

The impact of COVID-19 on people with cardiovascular disease and other chronic illnesses

April 27, 2020

We spoke with HMRI Cardio-oncologist Professor Aaron Sverdlov about why people with chronic conditions, such as cardiovascular disease, cancer and diabetes, are at greater risk from COVID-19.

HMRI leading a coordinated approach to clinical trials on COVID-19

April 23, 2020

The Hunter Medical Research Institute (HMRI) Clinical Trials Unit is playing a key role in supporting a major nationwide study testing potential treatments for coronavirus, COVID-19.

Clinical trial to repurpose existing drugs for COVID-19 treatments

April 21, 2020

HMRI is delighted to be involved in a new clinical trial aimed at testing the safety and efficacy of existing drugs for patients hospitalised with COVID-19.

Professor Hubert Hondermarck and Associate Professor Nathan Bartlett

Drug repurposing potential for COVID-19

April 17, 2020

Professor Hubert Hondermarck and Associate Professor Nathan Bartlett are researching drug repurposing to offer hope in fast-tracking treatments for COVID-19.